Pre-eclampsia surgery: Difference between revisions
Sam Norris (talk | contribs) |
|||
| (13 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Pre-eclampsia}} | {{Pre-eclampsia}} | ||
{{CMG}} {{AE}} {{Sara.Zand}} | {{CMG}} {{AE}} {{Sara.Zand}} | ||
==Overview== | |||
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence of any of the following: repeated episodes of [[severe hypertension]] ([[blood pressure]]≥ 160/110 mmHg), despite maintenance treatment with 3 classes of [[antihypertensive agents]], progressive [[thrombocytopenia]], progressively abnormal [[renal]] or [[liver]] enzyme tests, [[pulmonary edema]], abnormal [[neurological features]], [[stroke]], [[myocardial infarction]], [[ HELLP syndrome]], [[eclampsia]], suspected acute [[placental abruption]] or [[vaginal bleeding]] in the absence of [[placenta previa]], abnormal fetal testing, [[ fetal death]], fetus without expectation for survival at the time of maternal diagnosis (lethal anomaly, extreme [[prematurity]]), or persistent reversed end-diastolic flow in the [[umbilical artery]]. | |||
== Delivery == | == Delivery == | ||
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | [[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence of any of the following:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | ||
:*Repeated episodes of [[severe hypertension]] despite maintenance treatment with 3 classes of [[antihypertensive agents]] | :*Repeated episodes of [[severe hypertension]] ([[blood pressure]]≥ 160/110 mmHg, despite maintenance treatment with 3 classes of [[antihypertensive agents]]) | ||
:*Progressive [[thrombocytopenia]] | :*Progressive [[thrombocytopenia]] | ||
:*Progressively abnormal [[renal]] or [[liver]] enzyme tests | :*Progressively abnormal [[renal]] or [[liver]] enzyme tests | ||
:*[[Pulmonary edema]] | :*[[Pulmonary edema]] | ||
:*Abnormal [[ neurological features]], such as severe intractable [[ headache]], repeated [[visual scotomata]],[[ convulsions]] | :*Abnormal [[ neurological features]], such as severe intractable [[ headache]], repeated [[visual scotomata]], [[ convulsions]],[[Visual disturbances]], [[motor deficit]], [[alteredsensorium]] | ||
:* | :*[[ Stroke]] | ||
:*[[ Myocardial infarction]] | |||
:*[[ HELLP syndrome]] ([[hemolysis]], elevated [[liver]] enzymes, low [[platelet]]) | |||
:* [[Eclampsia]] | |||
:* Suspected acute [[placental abruption]] or [[vaginal bleeding]] in the absence of [[placenta previa]] | |||
:*Abnormal fetal testing | |||
:*[[ Fetal death]] | |||
:* Fetus without expectation for survival at the time of maternal diagnosis (lethal anomaly, extreme [[prematurity]]) | |||
:* Persistent reversed end-diastolic flow in the [[umbilical artery]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Up-to-date]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
| Line 19: | Line 30: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 15:00, 8 March 2021
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia surgery On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence of any of the following: repeated episodes of severe hypertension (blood pressure≥ 160/110 mmHg), despite maintenance treatment with 3 classes of antihypertensive agents, progressive thrombocytopenia, progressively abnormal renal or liver enzyme tests, pulmonary edema, abnormal neurological features, stroke, myocardial infarction, HELLP syndrome, eclampsia, suspected acute placental abruption or vaginal bleeding in the absence of placenta previa, abnormal fetal testing, fetal death, fetus without expectation for survival at the time of maternal diagnosis (lethal anomaly, extreme prematurity), or persistent reversed end-diastolic flow in the umbilical artery.
Delivery
Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence of any of the following:[1]
- Repeated episodes of severe hypertension (blood pressure≥ 160/110 mmHg, despite maintenance treatment with 3 classes of antihypertensive agents)
- Progressive thrombocytopenia
- Progressively abnormal renal or liver enzyme tests
- Pulmonary edema
- Abnormal neurological features, such as severe intractable headache, repeated visual scotomata, convulsions,Visual disturbances, motor deficit, alteredsensorium
- Stroke
- Myocardial infarction
- HELLP syndrome (hemolysis, elevated liver enzymes, low platelet)
- Eclampsia
- Suspected acute placental abruption or vaginal bleeding in the absence of placenta previa
- Abnormal fetal testing
- Fetal death
- Fetus without expectation for survival at the time of maternal diagnosis (lethal anomaly, extreme prematurity)
- Persistent reversed end-diastolic flow in the umbilical artery
References
- ↑ "Gestational Hypertension and Preeclampsia". Obstetrics & Gynecology. 135 (6): e237–e260. 2020. doi:10.1097/AOG.0000000000003891. ISSN 0029-7844.